Malarial Cytokine Responses Reduced by Age in Exposed Children
|
By LabMedica International staff writers Posted on 10 Jan 2018 |

Image: The MAGPIX CCD Imager, a compact multiplexing unit (Photo courtesy of Luminex).
Elevated levels of pro-inflammatory cytokines and chemokines in the peripheral blood during acute malaria infection contribute to the control of parasitemia, but are also responsible for much of the immunopathology seen during symptomatic disease.
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity.
An international team of scientists working with those at University of California San Francisco (CA, USA) obtained blood samples from study cohort that was initiated in 2011 and is ongoing. This cohort consists of 100 households where malaria transmission in this region is holoendemic, with an annual entomological inoculation rate (EIR) of 310 infective bites per person year. In total, plasma samples from 48 children were analyzed: 25 from children 1 to 3 years old and 23 from children 7 to 10 years old.
Thick blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were evaluated for the presence of parasitemia (asexual forms only) and gametocytes. The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology. Fourteen cytokines and six chemokines were analyzed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit and read on a Luminex MAGPIX CCD Imager. Human interferon gamma (IFNγ) OptEIA ELISA II Kits were used to quantify IFNγ levels in plasma.
The team found that younger children presenting with acute malaria exhibited much higher levels of tumor necrosis factor (TNF), interleukin-2 (IL2), and IL6, as well as increased T helper cells (Th1) associated chemokines interferon gamma-induced protein 10 (IP10), Monokine induced by gamma interferon (MIG), and monocyte chemoattractant protein-1 (MCP1), was compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and tumor necrosis factor receptor 1 (TNFRI) were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
The authors concluded that that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travelers; however, they also show increased levels of the regulatory cytokines IL10 and soluble TNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. The study was published on December 29, 2017, in the Malaria Journal.
Related Links:
University of California San Francisco
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity.
An international team of scientists working with those at University of California San Francisco (CA, USA) obtained blood samples from study cohort that was initiated in 2011 and is ongoing. This cohort consists of 100 households where malaria transmission in this region is holoendemic, with an annual entomological inoculation rate (EIR) of 310 infective bites per person year. In total, plasma samples from 48 children were analyzed: 25 from children 1 to 3 years old and 23 from children 7 to 10 years old.
Thick blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were evaluated for the presence of parasitemia (asexual forms only) and gametocytes. The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology. Fourteen cytokines and six chemokines were analyzed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit and read on a Luminex MAGPIX CCD Imager. Human interferon gamma (IFNγ) OptEIA ELISA II Kits were used to quantify IFNγ levels in plasma.
The team found that younger children presenting with acute malaria exhibited much higher levels of tumor necrosis factor (TNF), interleukin-2 (IL2), and IL6, as well as increased T helper cells (Th1) associated chemokines interferon gamma-induced protein 10 (IP10), Monokine induced by gamma interferon (MIG), and monocyte chemoattractant protein-1 (MCP1), was compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and tumor necrosis factor receptor 1 (TNFRI) were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
The authors concluded that that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travelers; however, they also show increased levels of the regulatory cytokines IL10 and soluble TNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. The study was published on December 29, 2017, in the Malaria Journal.
Related Links:
University of California San Francisco
Latest Microbiology News
- Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
- FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
- One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
- FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
- New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment
- Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories
- Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens
- Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk
- FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing
- Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus
- Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs
- Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing
- Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures
- Infant Skin Microbiome Show Links to Later Eczema and Food Allergies
- Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
- Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification
Channels
Clinical Chemistry
view channel
UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care
Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more
Noninvasive AI-Enabled Raman Probe Distinguishes Skin Cancers from Normal Tissue
Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas.... Read more
Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders
Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read moreMolecular Diagnostics
view channel
Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families
Hereditary cancer risk can extend beyond an individual patient to parents, siblings, and children. Although BRCA1 and BRCA2 mutations are linked to elevated risks of breast, ovarian, prostate, and other... Read more
Urine-Based RNA Improves Bladder Cancer Detection and Monitoring
Bladder cancer affects about 85,000 people in the United States each year and is prone to recurrence. Diagnosis and surveillance commonly rely on cystoscopy, an endoscopic examination that can miss up... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreMicrobiology
view channel
Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more
One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more
FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read morePathology
view channel
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. Residual tumor cells may contribute to recurrence and... Read more
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Collaboration Advances Automated Benchtop Platform for Routine Blood Testing
Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment
CellCarta (Montreal, Canada) and Imagene AI (Miami, FL, USA) have expanded their collaboration to provide biopharma companies with a coordinated pathway for biomarker strategy, assay development, validation,... Read more
Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection
Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more







